Ioana-Alina Anca *, Mirella-Maria Marinescu **
* Ioana-Alina Anca, Spitalul Clinic de Pediatrie “Prof. Dr. Alfred Rusescu”
** Mirella-Maria Marinescu, reprezentantă Leciva a.s.
Abstract
Initial results (1998) of a clinical trial with Adiuretin (desmopressin) nasal spray, favorable in 15/15 children suffering from monosimptomatic nocturnal enurezis, have been reevaluated after a 36 months follow-up period. The increased number of rebounds (10/13 reevaluated patients) is according the ulterior personal experience and the international published results: the long-term therapy with desmopressin (minimum 3 – 6 months) plays an important role in maintaining the therapeutic efficacy.